Results 101 to 110 of about 4,011 (178)

An Early Single-Center Case Series Experience With a Recently Introduced Formulation of Inhaled Treprostinil (Yutrepia). [PDF]

Cureus
Moore CR, Sharma M, Kim AI, Ghamande S, Yau P.   +4 more
europepmc   +1 more source

Treprostinil reduces blood pressure and aortic inflammation in hypertension. [PDF]

Clin Sci (Lond)
AlMotairy R, Ullah MM, Blessinger S, Lunel AM, Fehrenbach DJ, Zhang J, Szarkowicz C, Ceneviva ZJ, Wang J, Madhur MS, Shuey MM, Bastarache L, Peebles RS, Norlander AE.   +13 more
europepmc   +1 more source

Long-Term Subcutaneous Treprostinil in Pediatric Pulmonary Arterial Hypertension at a Latin American Referral Center: A Retrospective Cohort Study. [PDF]

Pulm Circ
Valencia Salazar A, Vallejo Mondragón EL.   +1 more
europepmc   +1 more source

Group 3 Pulmonary Hypertension: Mechanistic Insights, Clinical Challenges, and Evolving Therapies. [PDF]

J Clin Med
Liu SC, Ku M, Mohnani P, Borse T, Bajantri B.   +4 more
europepmc   +1 more source

A Phase 2 Study of the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Patients With Pulmonary Hypertension Associated With Interstitial Lung Disease. [PDF]

Pulm Circ
Church C, Molina-Molina M, Arias-Guillén M, Muchmore P, Lavon BR, Backer J, Makulova N, Mistry B, Guo J, Wu J, Fahumy J, Teper A, Zhao PL, Mange KC, O'Brien G.   +14 more
europepmc   +1 more source

Pseudo-Infarction Reversal in Right Precordial Leads: ECG Evolution in Severe Pulmonary Hypertension. [PDF]

JACC Case Rep
Wang L, Cui Y, Song J, Zhao Q, Lee C, Song J.   +5 more
europepmc   +1 more source

Early postoperative treprostinil in for severe pulmonary arterial hypertension in a high-risk pediatric patient with complete atrioventricular septal defect: a case report. [PDF]

BMC Cardiovasc Disord
Zhao S, Lu ZY, Zhou P, Xiong L, Li XB.
europepmc   +1 more source

Pulmonary hypertension associated with interstitial lung disease: a state-of-the-art review. [PDF]

Eur Respir J
Raghu G, Sahay S, Price LC, Weatherald J, Rayner SG, Behr J, Boucly A, Das M, McLaughlin V, Rahaghi F, Rutland C, Ryu JH, Saggar R, Humbert M.   +13 more
europepmc   +1 more source

Inhaled Treprostinil in PH-ILD: Interpreting Claims-Based Reductions in Hospitalizations. [PDF]

Pulm Circ
Narra T.
europepmc   +1 more source

Disease Mechanisms and Therapeutic Advances in Idiopathic and Progressive Pulmonary Fibrosis: From Approved Drugs to Emerging Strategies. [PDF]

J Clin Med
Tirelli C, Muscato G, Alaimo C, Di Leo I, Mirijaj S, Pennisi F, Vancheri C, Mondoni M.   +7 more
europepmc   +1 more source